Top News
Surescripts settles Federal Trade Commission charges from 2019 that accused the company of anti-competitive practices in the electronic prescribing and eligibility markets.
FTC claimed that Surescripts maintained a 95% market share in both…
By Jill McKeon
June 20, 2023 – The Federal Trade Commission (FTC) reached a proposed settlement with 1Health.io, a genetic testing company, over its alleged security and privacy failures. The order requires the company to pay…
Continue Reading
The Federal Trade Commission (FTC) is proposing changes to its breach notification rule to include apps and connected devices that collect personal health information. The proposed changes would require these companies to notify consumers and the…
Continue Reading
By Sarai Rodriguez
May 22, 2023 – The rapid growth of digital healthcare apps in the United States has brought both advantages and concerns regarding privacy and efficacy.
In response, the Federal Trade Commission (FTC) has invited…
Continue Reading
The Federal Trade Commission is seeking to amend and expand its Health Breach Notification Rule, or HBNR, to cover entities not previously covered by HIPAA, allow them to use email and other electronic data…
Continue Reading
Fertility tracking app Premom, owned by Easy Healthcare, came under fire by the Federal Trade Commission, which alleged the company shared consumers’ health data with third parties like Google, AppsFlyer and two China-based analytics…
Continue Reading
The American Hospital Association and five other hospital associations have urged the Federal Trade Commission to abandon its policy of enforcing the Hart-Scott-Rodino Act against state-approved mergers and acquisitions. The groups argue that the…
Continue Reading
Sen. Elizabeth Warren (D-Mass.) is urging the Federal Trade Commission to scrutinize CVS Health’s planned acquisition of Medicare-focused primary care provider Oak Street Health. In a letter to FTC Chair Lina Khan and Commissioners Alvaro…
Continue Reading
In its 2024 budget proposal, the Federal Trade Commission requested an overall increase of $160 million to increase staffing levels, cover the increased costs of operations and provide employee pay increases.Pursuing anti-competitive tactics and…
Continue Reading
Seagen, the biotech company Pfizer is buying for $43 billion, is considered a pioneer in the class of cancer drugs called antibody drug conjugates. But the first ADC to reach the market wasn’t a…
Continue Reading
